Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Jan;77(1):559-62.
doi: 10.1073/pnas.77.1.559.

Antibody-independent activation of the alternative complement pathway by measles virus-infected cells

Antibody-independent activation of the alternative complement pathway by measles virus-infected cells

J G Sissons et al. Proc Natl Acad Sci U S A. 1980 Jan.

Abstract

When HeLa cells acutely infected with measles virus were incubated in a mixture containing only the six proteins of the alternative pathway of complement activation (C3, factors B and D, beta 1H, C3b inactivator, and native properdin) without antibody, there was activation of the alternative pathway as shown by progressive uptake of 125I-labeled C3b onto the cell surface. This C3b uptake was blocked by EDTA and was not shown by uninfected cells. The rate of 125I-labeled C3 uptake by infected cells was the same in the absence and presence of properdin; however, when antiviral IgG was bound to the cell surface, the rate of C3 uptake was increased in the presence of properdin. Significant 125I-labeled C3 uptake was first detectable when cells were studied at 12 hr after infection, when cells expressed viral polypeptides on their surface. There was also progressive uptake of 125I-labeled C3 onto measles virus-infected cells incubated in human serum depleted of both IgG and C4. Hence, the human alternative pathway of complement activation can be initiated on the surface of measles virus-infected cells independent of IgG antibody. However, lysis of the infected cells only occurs when antiviral antibody is present.

PubMed Disclaimer

References

    1. J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s - PubMed
    1. J Exp Med. 1956 Nov 1;104(5):707-25 - PubMed
    1. Annu Rev Microbiol. 1971;25:283-90 - PubMed
    1. Biochemistry. 1974 Feb 26;13(5):1014-21 - PubMed
    1. J Exp Med. 1975 Apr 1;141(4):761-74 - PubMed

Publication types